Reference
Hoogendoorn M, et al. Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios. Value in Health 17: 525-36, No. 5, Jul 2014. Available from: URL: http://doi.org/10.1016/j.jval.2014.03.1721
Rights and permissions
About this article
Cite this article
Mortality important in COPD cost-effectiveness models. PharmacoEcon Outcomes News 710, 17 (2014). https://doi.org/10.1007/s40274-014-1490-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1490-y